
The industry is going through a period of transition, primarily due to increased sanctions by US Food and Drug Administration (USFDA), which has banned several units from shipping drugs to the United States.
from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2A4BdpR
via
IFTTT
0 comments:
Post a Comment